We are revolutionizing the translational potential of animal models in preclinical research. Discover the latest articles and news about our recent activities.
7 September 2022
PhoenixBio is thrilled to be attending the International HBV Meeting in person at the Novotel Paris Centre Tour Eiffel in Paris, France on September 18th - 22nd, 2022. Meet with our team to learn more about PhoenixBio's capabilities and how we can help you advance future therapies for viral hepatitis (HBV, HDV/HBV, HCV), Gene Editing, Gene Therapy, Drug Metabolism, Pharmacokinetics, and Toxicology.
8 June 2022
PhoenixBio is thrilled to be attending EASL's International Liver Congress in person at the ExCeL in London, UK on June 22nd - 26th, 2022. Meet with our team to learn more about PhoenixBio's capabilities and how we can help you advance future therapies for HBV, HDV/HBV, HCV, NASH/NAFLD, Gene Editing, Gene Therapy, Drug Metabolism, Pharmacokinetics, and Toxicology.
12 May 2022
PhoenixBio is delighted to be attending ASGCT in person at the Walter E. Washington Convention Center in Washington, DC on May 16 - 19, 2022. Meet with our team to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s therapies.
1 March 2021
PhoenixBio is pleased to be participating in the 2021 Society of Toxicology Annual Meeting.
